Abstract
Research into chronic obstructive pulmonary disease (COPD) has identified different phenotypes, which require a variety of approaches to treatment. As a result, the Global Obstructive Lung Disease (GOLD) guidelines group has updated its advice on the diagnosis and management of COPD. The 2017 GOLD guidelines offer a fresh approach to the identification and management of these COPD phenotypes, so that inhaled therapies and other treatments can be offered appropriately both in stable and acute exacerbations of COPD. This article reviews the treatment options as suggested by the GOLD guidelines group and discusses the rationale for taking a risk: benefit approach to treatment decisions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
